https://www.marketscreener.com/quote/stock/HUTCHMED-CHINA-LIMITED-26786463/news/HUTCHMED-Initiates-Rolling-Submission-of-NDA-to-U-S-FDA-for-Fruquintinib-for-the-Treatment-of-Refra-42576286/?utm_source=telegram&utm_medium=social&utm_campaign=share